ML
Manuel MD Litchman
President, CEO and Interim CFODirector

Manuel MD Litchman insider trades: Mustang Bio (MBIO) stock buys and sales

President, CEO and Interim CFO, Mustang Bio Last trade Sep 13, 2022 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Manuel reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 13, 2022MBIO↑ Buy$6K
Oct 27, 2021MBIO↑ Buy$146K
Jul 30, 2021MBIO↑ Buy$251K
Mar 5, 2021MBIO↑ Buy$517K
Dec 15, 2020MBIO↑ Buy$291K
Jun 11, 2020MBIO↑ Buy$500K
May 22, 2020MBIO↓ Sell$38K
May 21, 2020MBIO↑ Buy$533K
Dec 10, 2018MBIO↑ Buy$104K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Manuel MD Litchman's insider trades

Manuel MD Litchman is President, CEO and Interim CFO at Mustang Bio (MBIO). Since Dec 10, 2018, Manuel has reported 8 open-market purchases worth $2.3M and 1 sale worth $38K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.